Generic TRK Inhibitor for NTRK Fusion Cancers

Larotrectinib is a pill designed to target TRK, which is a type of inhibitor. It zeroes in on a specific gene called NTRK, which includes TRKA, TRKB, and TRKC, to stop tumors from growing. It’s made to help with really tough cancers that can’t be removed or have spread, in both kids and grown-ups.

Available in three forms: 25 mg or 100 mg capsules and a 20 mg/mL oral solution, the recommended adult dosage is 100 mg twice daily, with pediatric dosing based on body surface area. The medicine comes in bottles with 60 pills each.